| The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update M Maurer, M Magerl, I Ansotegui, E Aygören-Pürsün, S Betschel, K Bork, ... World Allergy Organization Journal 11, 1-20, 2018 | 881* | 2018 |
| The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency Z Zotter, D Csuka, E Szabó, I Czaller, Z Nébenführer, ... Orphanet journal of rare diseases 9, 1-6, 2014 | 171 | 2014 |
| Complement activation in thrombotic thrombocytopenic purpura M Reti, P Farkas, D Csuka, K Razso, A Schlammadinger, ML Udvardy, ... Journal of Thrombosis and Haemostasis 10 (5), 791-798, 2012 | 168 | 2012 |
| The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey I Czaller, B Visy, D Csuka, G Füst, F Tóth, H Farkas European Journal of Obstetrics & Gynecology and Reproductive Biology 152 (1 …, 2010 | 149 | 2010 |
| Short‐term prophylaxis in hereditary angioedema due to deficiency of the C 1‐inhibitor–a long‐term survey H Farkas, Z Zotter, D Csuka, E Szabó, Z Nébenfűhrer, ... Allergy 67 (12), 1586-1593, 2012 | 120 | 2012 |
| Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report A Kronbichler, R Frank, M Kirschfink, A Szilagyi, D Csuka, Z Prohaszka, ... Medicine 93 (26), e143, 2014 | 111 | 2014 |
| Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection G Sinkovits, B Mező, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, ... Frontiers in immunology 12, 663187, 2021 | 102 | 2021 |
| Long‐term efficacy of danazol treatment in hereditary angioedema G Füst, H Farkas, D Csuka, L Varga, K Bork European journal of clinical investigation 41 (3), 256-262, 2011 | 68 | 2011 |
| The effect of long-term danazol prophylaxis on liver function in hereditary angioedema—a longitudinal study H Farkas, I Czaller, D Csuka, A Vas, S Valentin, L Varga, G Széplaki, ... European journal of clinical pharmacology 66, 419-426, 2010 | 68 | 2010 |
| International consensus on the use of genetics in the management of hereditary angioedema AE Germenis, M Margaglione, JB Pesquero, H Farkas, S Cichon, D Csuka, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (3), 901-911, 2020 | 67 | 2020 |
| Maternal and fetal outcomes of pregnancies in women with atypical hemolytic uremic syndrome M Gaggl, C Aigner, D Csuka, Á Szilágyi, Z Prohászka, R Kain, N Haninger, ... Journal of the American Society of Nephrology 29 (3), 1020-1029, 2018 | 66 | 2018 |
| Psychometric field study of hereditary angioedema quality of life questionnaire for adults: HAE-QoL N Prior, E Remor, E Pérez-Fernández, M Caminoa, C Gómez-Traseira, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (3), 464-473. e4, 2016 | 65 | 2016 |
| The phenotypic spectrum of nephropathies associated with mutations in diacylglycerol kinase ε K Azukaitis, E Simkova, MA Majid, M Galiano, K Benz, K Amann, ... Journal of the American Society of Nephrology 28 (10), 3066-3075, 2017 | 58 | 2017 |
| F12‐46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema M Speletas, Á Szilágyi, D Csuka, N Koutsostathis, F Psarros, D Moldovan, ... Allergy 70 (12), 1661-1664, 2015 | 58 | 2015 |
| Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations A Bors, D Csuka, L Varga, H Farkas, A Tordai, G Füst, A Szilagyi Journal of Allergy and Clinical Immunology 131 (6), 1708-1711. e3, 2013 | 54 | 2013 |
| Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency D Csuka, N Veszeli, É Imreh, Z Zotter, J Skopál, Z Prohászka, L Varga, ... Orphanet Journal of Rare Diseases 10, 1-13, 2015 | 50 | 2015 |
| Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema Z Kelemen, D Moldovan, E Mihály, B Visy, G Széplaki, D Csuka, G Füst, ... Clinical Immunology 134 (3), 354-358, 2010 | 48 | 2010 |
| The levels of the lectin pathway serine protease MASP-1 and its complex formation with C1 inhibitor are linked to the severity of hereditary angioedema CB Hansen, D Csuka, L Munthe-Fog, L Varga, H Farkas, KM Hansen, ... The Journal of Immunology 195 (8), 3596-3604, 2015 | 45 | 2015 |
| Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency G Loules, M Zamanakou, F Parsopoulou, S Vatsiou, F Psarros, D Csuka, ... Gene 667, 76-82, 2018 | 44 | 2018 |
| Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients H Farkas, D Csuka, Z Zotter, E Szabó, I Czaller, L Varga, J Fejes, G Füst, ... Journal of Allergy and Clinical Immunology 131 (3), 909-911. e5, 2013 | 43 | 2013 |
